+
Site Tour

Search

Showing 101 - 110 of 459 results.

  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  LEARN MORE: Talisman vs. Gore   Talisman vs. Occlutech THE PFO OCCLUDER

  • Guidelines & Recommendations

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion 2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGE

  • Patients who benefit

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion

  • Overview

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion AF AND THE CHALLENGES OF MEDICATION Many patients at risk of str

  • Patients who benefit

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion

  • EPIC™ Max Clinical Data

    AT 10 YEARS LEARN MORE: EPIC MAX BROCHURE COMMITED TO VALVE-IN-VALVE* FOLLOW-UP DATA 3-YEAR OUTCOMES OF VALVE-IN-VALVE INTERVENTION IN A U.S. POPULATION Maximizing the internal orifice prov

  • Clinical Data

    SVD: structural valve deterioration. *From stand-alone aortic or mitral valve replacements.   THE EPIC PLATFORM HAS DEMONSTRATED EXCELLENT DURABILITY IN YOUNGER PATIENTS The Epic Mitral va

  • Overview

    HEART FAILURE IS AFFECTING A GROWING NUMBER OF PATIENTS With the complexity and rise in prevalence of heart failure, the Heart Failure Association of the European Society of Cardiology aims to make

  • Guidelines & Recommendations

    2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)4-7 ACCESS TO

  • Diagnosis

    AF AND STROKE ARE OFTEN CONNECTED MORE SEVERE LEARN MORE: PATIENTS WHO BENEFIT Clinical Data

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline